Edges in Network
| Network | GSE16391_top500tf - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | NFE2L2 |
| Upstream (Parents) |
|---|
| (<<) CUX2 → NFE2L2 |
| (<<) RUNX1 → NFE2L2 |
| (<<) TGIF2 → NFE2L2 |
| (<<) SP1 → NFE2L2 |
| (<<) YEATS4 → NFE2L2 |
| (<<) MLL → NFE2L2 |
| (<<) RBCK1 → NFE2L2 |
| (<<) TCF3 → NFE2L2 |
| (<<) ZNF18 → NFE2L2 |
| (<<) SCML2 → NFE2L2 |
| (<<) GABPB1 → NFE2L2 |
| Downstream (Children) |
|---|
| NFE2L2 → PITX1 (>>) |
| NFE2L2 → HEY2 (>>) |
| NFE2L2 → NFIA (>>) |
| NFE2L2 → AFF4 (>>) |
| NFE2L2 → NFAT5 (>>) |
| NFE2L2 → NR1H3 (>>) |
| NFE2L2 → TFCP2 (>>) |
| NFE2L2 → FOXK1 (>>) |
| NFE2L2 → ETV5 (>>) |
| NFE2L2 → SMAD5 (>>) |
| NFE2L2 → PA2G4 (>>) |
| NFE2L2 → MTF1 (>>) |
| NFE2L2 → BRD8 (>>) |
